Skip to content

Role of autonomic nervous system and adrenoceptor gene mutation in Takotsubo Cardiomyopathy

Role of autonomic nervous system and adrenoceptor gene mutation in Takotsubo Cardiomyopathy - Role of autonomic nervous system and adrenoceptor gene mutation in Takotsubo Cardiomyopathy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000017000
Enrollment
80
Registered
2015-03-31
Start date
2015-03-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Takotsubo cardiomyopathy

Interventions

We will assess the stress reaction after we perform the standard autonomic function test of participants. All the medications which might affect the autonomic nervous system were withheld for at lea
self introduction, a funny story of recent or a touching tale. They will speech in front of the medical profession(s) for 3 minutes.

Sponsors

Tokyo Women's Medical University
Lead Sponsor
Tokai University
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: A. Definition criteria of TCM 1. Transient hypokinesis, akinesis, or dyskinesis of the left ventricular midsegments with or without apical involvement; the regional wall motion abnormalities extend beyond a single epicardial vascular distribution; a stressful trigger is often, but not always present. 2. Absence of obstructive coronary disease or angiographic evidence of acute plaque rupture. 3. New electrocardiographic abnormal- ities (either ST-segment elevation and/or T-wave inversion) or modest elevation of cardiac troponin. 4. Absence of:recent significant head trauma, intracranial bleeding, pheochromocytoma, myocarditis, hypertrophic cardiomyopathy. B. Subjects inclusion criteria 1. Age >= 20 years old. 2. TCM patietns: History of TCM more than the prior 3 weeks with well-preserved general condition. 3. Healthy subjects: Matched by a comparable age and sex of TCM patients.

Exclusion criteria

Exclusion criteria: 1. Patients who have uncontrolled cardiovascular diseases such as congestive heart failure, ischemic heart disease, hypertension, arrhythmia 2. Patients who have uncontrolled diabetes meltis 3. Pregnant or lactating women 4. Patients who have overt concomitant disease 5. Patients who are not eligible for this study by study doctors

Design outcomes

Primary

MeasureTime frame
The primary outcome is plasma norepinephrine and epinephrine during the stress test between TCM and healthy subjects.

Secondary

MeasureTime frame
The secondly outcome is blood pressure, heart rate, indexes of autonomic function test and genetic polymorphisms of adrenoceptors between TCM and control subjects.

Countries

Japan

Contacts

Public ContactKyoko Sato

Tokyo Women's Medical University, East Medical Center Department of Medicine

satokgm@dnh.twmu.ac.jp03-3810-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026